News

Taipei, Taiwan   Following a rigorous review by Boehringer Ingelheim’s corporate venture arm, interdisciplinary research teams, and business development experts, six biotech and digital health teams out of 89 submissions were named award winners of 2024 Boehringer Ingelheim BioMedicine Innovation Program. The winners represent a dynamic mix of innovators from clinical, academic, and industry backgrounds—with […]